Anondita Medicare Ltd vs Dra Consultants Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 16, 2026

Key Highlights

The Latest Trading Price of Anondita Medicare Ltd is ₹ 706.15 as of 16 Mar 15:30 . The P/E Ratio of Anondita Medicare Ltd is 0 as of March 2025 .The P/E Ratio of DRA Consultants Ltd is 0 as of March 2025 . The Market Cap of Anondita Medicare Ltd is ₹ 0 crore as of March 2025 .The Market Cap of DRA Consultants Ltd is ₹ 0 crore as of March 2025 . The Dividend Payout of Anondita Medicare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of DRA Consultants Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Anondita Medicare Ltd

Anondita Medicare Limited was incorporated as a Public Limited Company on March 12, 2024, with the Registrar of Companies, Central Registration Centre.
Prior to this, Company business was run by current promoter, Mr. Anupam Ghosh, as a sole proprietorship under the name of M/s Anondita Healthcare (formerly M/s Healthcare Products) from year 1999 onwards. Company is a manufacturer of male condoms with a variety of flavors, with our flagship product marketed and sold under the brand 'COBRA'.
It operate an installed production capacity of nearly 562 million condoms per annum, as per certificate issued by JP Sood, Chartered Engineer, dated November 21, 2024.
Further, to follow sustainable production practices, Company uses CNG as a clean, environmentally friendly manufacturing fuel for its manufacturing plant situated at Sector 80, Gautam Budh Nagar, Noida, Uttar Pradesh.

About DRA Consultants Ltd

DRA Consultants Limited was originally incorporated in Mumbai, as a proprietary firm in the year 1990, under the name and style of Dinesh Rathi and Associates.
Thereafter, a Company was formed by the Promoters, Dinesh Rathi and Uma Rathi, under the name and style of 'DRA Consultants Private Limited', on May 5, 2009, issued by Assistant Registrar of Companies.
Thereafter, Company acquired business of proprietary firm vide agreement dated June 30, 2009.
Subsequently, it converted into Public Limited Company, and the name was changed to 'DRA Consultants Limited'.
A fresh Certificate of Incorporation upon conversion from Private company to Public Company dated August 24, 2016, was issued by the Registrar of Companies. The Company is engaged mainly in the business of engineering consultancy in India.

FAQs for the comparison of Anondita Medicare Ltd and DRA Consultants Ltd

Which company has a larger market capitalization, Anondita Medicare Ltd or DRA Consultants Ltd?

Market cap of Anondita Medicare Ltd is 1,306 Cr while Market cap of DRA Consultants Ltd is 18 Cr

What are the key factors driving the stock performance of Anondita Medicare Ltd and DRA Consultants Ltd?

The stock performance of Anondita Medicare Ltd and DRA Consultants Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anondita Medicare Ltd and DRA Consultants Ltd?

As of March 16, 2026, the Anondita Medicare Ltd stock price is INR ₹722.1. On the other hand, DRA Consultants Ltd stock price is INR ₹17.08.

How do dividend payouts of Anondita Medicare Ltd and DRA Consultants Ltd compare?

To compare the dividend payouts of Anondita Medicare Ltd and DRA Consultants Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.